Compounds > betulinic acid

betulinic acid and Fatty Liver, Nonalcoholic

betulinic acid has been researched along with Fatty Liver, Nonalcoholic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Ge, X; Guo, S; Jiao, T; Li, C; Liu, Y; Nan, F; Wang, K; Wang, Y; Xie, C; Xie, X; Yin, J; Zhang, C1
Fang, Q; Han, L; Jin, L; Mu, Q; Ning, G; Qian, Z; Tong, L; Wang, H; Xiang, M; Yang, J; Zhang, Y; Zhang, Z1
Fan, S; Gu, M; Huang, C; Ji, G; Tong, Q; Yang, L; Zhang, S; Zhao, P1
Choi, BH; Fang, S; Hyun, CK; Jeon, J; Jung, HY; Kim, B; Kim, JB; Kim, KD; Kim, KT; Park, CH; Ryu, HG; Yang, SH; Yoo, HY1
Chung, SH; Jo, HK; Kim, DY; Kim, GW; Kim, SJ; Quan, HY1

Other Studies

5 other study(ies) available for betulinic acid and Fatty Liver, Nonalcoholic

ArticleYear
Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis.
    Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

    Topics: Animals; Betulinic Acid; Bile Acids and Salts; Ceramides; Fibrosis; Glucose; Inflammasomes; Inflammation; Islet Amyloid Polypeptide; Liver; Methionine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Receptors, Cytoplasmic and Nuclear

2022
Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:9

    Topics: Animals; Betulinic Acid; Fatty Acid Synthase, Type I; Fatty Acids; Hep G2 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Protective Agents; YY1 Transcription Factor

2020
Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice.
    British journal of pharmacology, 2019, Volume: 176, Issue:7

    Topics: Animals; Betulinic Acid; Endoplasmic Reticulum Stress; Female; Hep G2 Cells; Humans; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Triterpenes

2019
Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2019, Volume: 29, Issue:4

    Topics: 3T3-L1 Cells; Adipocytes; Adiposity; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Betulinic Acid; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Enzyme Activation; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Pentacyclic Triterpenes; Phosphorylation; Signal Transduction; Triterpenes; Weight Gain

2019
Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Biochemical pharmacology, 2013, May-01, Volume: 85, Issue:9

    Topics: AMP-Activated Protein Kinases; Animals; Betulinic Acid; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Line, Tumor; Cell Nucleus; Dietary Fats; Enzyme Activators; Fatty Liver; Hepatocytes; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Protein Transport; Rats; Ribosomal Protein S6 Kinases; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Proteins; TOR Serine-Threonine Kinases; Triglycerides; Triterpenes

2013